Monteverde & Associates Launches Inquiries Into Four Corporate Mergers

The New York-based firm, Monteverde & Associates PC, has opened investigations into the following pending deals: the acquisition of Crinetics Pharmaceuticals by Vertex Pharmaceuticals for $85.00 per share, the sale of Simulations Plus to affiliates of Altaris, LLC for $18.50 per share, the merger of NCS Multistage Holdings with Weatherford International, and the combination of Passage Bio with Remix Therapeutics. The firm, which maintains offices in the Empire State Building, is currently soliciting contact from shareholders who hold common stock in these companies to evaluate potential legal claims. Interested parties are invited to reach out to the firm for a review of their holdings at no cost or obligation. These investigations reflect the firm's ongoing effort to monitor corporate governance and officer conduct during high-stakes equity transactions.